$BOF
BranchOut Food Inc. Stock $bof

$bof Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000149315224012492 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$1.471M	$1.478M	$2.826M
YoY Change	1411.03%	5472.75%	275.69%
Cost Of Revenue	$1.183M	$1.667M	$2.922M
YoY Change	1563.05%	3416.69%	216.68%
Gross Profit	$283.6K	-$188.1K	-$96.23K
YoY Change	983.22%	801.77%	-43.58%
Gross Profit Margin	19.28%	-12.72%	-3.41%
Selling, General & Admin	$1.309M	$1.422M	$3.406M
YoY Change	126.87%	149.65%	58.99%
% of Gross Profit	461.48%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$56.34K	$56.34K	$223.9K
YoY Change	0.92%	0.9%	140.06%
% of Gross Profit	19.87%
Operating Expenses	$1.309M	$1.255M	$3.406M
YoY Change	106.85%	100.59%	52.35%
Operating Profit	-$1.025M	-$1.443M	-$3.502M
YoY Change	69.02%	123.21%	45.55%
Interest Expense	$28.74K	-$26.31K	-$423.6K
YoY Change	-116.85%	-94.87%	-81.07%
% of Operating Profit
Other Income/Expense, Net	-$25.87K		-$423.6K
YoY Change	-84.84%
Pretax Income	-$1.051M	-$1.469M	-$3.926M
YoY Change	35.24%	-20.86%	-15.46%
Income Tax
% Of Pretax Income
Net Earnings	-$1.051M	-$1.469M	-$3.926M
YoY Change	35.24%	-20.86%	-15.46%
Net Earnings / Revenue	-71.45%	-99.37%	-138.92%
Basic Earnings Per Share	-$0.26		-$1.44
Diluted Earnings Per Share	-$0.26	-$0.36	-$1.44
COMMON SHARES
Basic Shares Outstanding	4.044M shares	4.044M shares	2.726M shares
Diluted Shares Outstanding	4.109M shares		2.726M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$251.7K	$657.8K	$657.8K
YoY Change	25.72%	110.36%	110.36%
Cash & Equivalents	$0.00	$0.00
Short-Term Investments
Other Short-Term Assets	$79.54K	$28.57K	$28.57K
YoY Change	-93.95%	-94.26%	-97.23%
Inventory	$118.1K	$336.8K	$336.8K
Prepaid Expenses
Receivables	$500.0K	$635.6K	$635.6K
Other Receivables	$22.38K	$19.53K	$19.53K
Total Short-Term Assets	$1.269M	$1.678M	$1.678M
YoY Change	-32.37%	55.68%	3.49%
LONG-TERM ASSETS
Property, Plant & Equipment	$908.7K	$1.062M	$1.062M
YoY Change	-5.98%	3.91%	3.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Assets	$1.422M	$1.447M	$1.447M
YoY Change	-10.38%	-33.82%	-11.92%
TOTAL ASSETS
Total Short-Term Assets	$1.269M	$1.678M	$1.678M
Total Long-Term Assets	$1.422M	$1.447M	$1.447M
Total Assets	$2.691M	$3.125M	$3.125M
YoY Change	-22.29%	-4.26%	-4.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$409.1K	$383.0K	$383.0K
YoY Change	-11.82%	36.73%	36.73%
Accrued Expenses	$78.10K	$165.2K	$165.2K
YoY Change	-90.09%	-76.01%	-76.01%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Long-Term Debt Due	$382.6K	$230.9K	$230.9K
YoY Change	-95.2%	-96.84%	-96.84%
Total Short-Term Liabilities	$869.8K	$779.1K	$779.1K
YoY Change	-90.64%	-90.69%	-90.69%
LONG-TERM LIABILITIES
Long-Term Debt	$127.3K	$135.5K	$135.5K
YoY Change	268.87%	292.84%	292.84%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$127.3K	$135.5K	$135.5K
YoY Change	268.87%	292.84%	292.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$869.8K	$779.1K	$779.1K
Total Long-Term Liabilities	$127.3K	$135.5K	$135.5K
Total Liabilities	$997.1K	$914.6K	$914.6K
YoY Change	-89.31%	-89.12%	-89.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$13.86M	-$12.81M
YoY Change		44.18%
Common Stock	$15.52M	$15.02M
YoY Change		301.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.694M	$2.210M	$2.210M
YoY Change
Total Liabilities & Shareholders Equity	$2.691M	$3.125M	$3.125M
YoY Change	-22.29%	-4.26%	-4.26%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$1.051M	-$1.469M	-$3.926M
YoY Change	35.24%	-20.86%	-15.46%
Depreciation, Depletion And Amortization	$56.34K	$56.34K	$223.9K
YoY Change	0.92%	0.9%	140.06%
Cash From Operating Activities	-$503.6K	-$271.1K	-$3.529M
YoY Change	-23.3%	-40.29%	43.02%
INVESTING ACTIVITIES
Capital Expenditures	$50.00K	$50.00K	$116.6K
YoY Change			158.18%
Acquisitions
YoY Change
Other Investing Activities	$9.900K	$0.00	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$40.10K	-$50.00K	-$116.6K
YoY Change			419.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$6.226M
YoY Change			62160.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$137.6K	-29.57K	3.755M
YoY Change	-74.71%	-105.58%	72.06%
NET CHANGE
Cash From Operating Activities	-$503.6K	-271.1K	-3.529M
Cash From Investing Activities	-$40.10K	-50.00K	-116.6K
Cash From Financing Activities	$137.6K	-29.57K	3.755M
Net Change In Cash	-$406.1K	-350.7K	109.3K
YoY Change	261.03%	-560.4%	-135.54%
FREE CASH FLOW
Cash From Operating Activities	-$503.6K	-$271.1K	-$3.529M
Capital Expenditures	$50.00K	$50.00K	$116.6K
Free Cash Flow	-$553.6K	-$321.1K	-$3.646M
YoY Change	-15.69%	-29.28%	45.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001962481
CY2023Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases		usd
CY2023Q4	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent		usd
CY2023Q4	us-gaap	Deferred Costs DeferredCosts		usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023	us-gaap	Depreciation Depreciation		usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022	BOF	Increase Decrease In Rightofuse Asset IncreaseDecreaseInRightofuseAsset		usd
CY2023	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable		usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2022	BOF	Initial Recognition Of Rightofuse Assets And Lease Liabilities InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities		usd
CY2023	BOF	Modification Of Derivative Liabilities ModificationOfDerivativeLiabilities		usd
CY2023Q4	BOF	Refunds Receivable RefundsReceivable		usd
CY2023Q4	BOF	Advances To Co Manufacturer AdvancesToCoManufacturer		usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount		usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount		usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants		usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo		usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree		usd
CY2023Q4	BOF	Long Term Debt Maturities Effects Of Discounting LongTermDebtMaturitiesEffectsOfDiscounting		usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization		usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense		usd
CY2022	BOF	Finance Lease Cost FinanceLeaseCost		usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability		usd
CY2022	BOF	Repayment Of Finance Lease Liability RepaymentOfFinanceLeaseLiability		usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite C
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	9598284	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4044252	shares
CY2023	dei	Auditor Firm AuditorFirmId	2738
CY2023	dei	Auditor Name AuditorName	M&K CPAS, PLLC
CY2023	dei	Auditor Location AuditorLocation	The Woodlands, TX
CY2023Q4	us-gaap	Cash Cash	657789	usd
CY2022Q4	us-gaap	Cash Cash	312697	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	635549	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	78236	usd
CY2022Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	29500	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	336805	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	159761	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	48100	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	497779	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	1678243	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1077973	usd
CY2022Q4	us-gaap	Restricted Cash Equivalents Noncurrent RestrictedCashEquivalentsNoncurrent	235750	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	543664	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	914999	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1022290	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	147228	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	384628	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	384628	usd
CY2023Q4	us-gaap	Assets Assets	3125098	usd
CY2022Q4	us-gaap	Assets Assets	3264305	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	165244	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	688722	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	200000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2250000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	91541	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	30901	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	779093	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8369533	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	34500	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	34500	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	101029	usd
CY2023Q4	us-gaap	Liabilities Liabilities	914622	usd
CY2022Q4	us-gaap	Liabilities Liabilities	8404033	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	8000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	8000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4044252	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4044252	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1200769	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1200769	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	4044	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	1201	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	15016973	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3743902	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12810541	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8884831	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2210476	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-5139728	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3125098	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3264305	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2825855	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	752178	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2922085	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	922728	usd
CY2023	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	1129858	usd
CY2022	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	628637	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	694596	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	583920	usd
CY2022	us-gaap	Depreciation Depreciation	93253	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	3405928	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	2235536	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-3502158	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2406086	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	11719	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	13627	usd
CY2023	us-gaap	Interest Expense InterestExpense	435271	usd
CY2022	us-gaap	Interest Expense InterestExpense	2250893	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-423552	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2237266	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3925710	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4643352	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2726330	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2726330	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1200157	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1200157	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.44
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.44
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.87
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.87
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1621832	usd
CY2022	BOF	Adjustments To Additional Paid In Capital Modification Of Derivatives AdjustmentsToAdditionalPaidInCapitalModificationOfDerivatives	630685	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	14050	usd
CY2022	BOF	Adjustments To Additional Paid In Capital Modification Of Warrants AdjustmentsToAdditionalPaidInCapitalModificationOfWarrants	377200	usd
CY2022	BOF	Stock Issued During Period Value Common Stock Sold For Cash StockIssuedDuringPeriodValueCommonStockSoldForCash	10000	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	24420	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	69101	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4643352	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-5139728	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-5139728	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4942046	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	159140	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	99434	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	6029204	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	46090	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3925710	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2210476	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	2210476	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3925710	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-4643352	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	223856	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	93253	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	66090	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1286021	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	761085	usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	159140	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	24420	usd
CY2023	BOF	Issuance Of Options And Warrants For Services IssuanceOfOptionsAndWarrantsForServices	99434	usd
CY2022	BOF	Issuance Of Options And Warrants For Services IssuanceOfOptionsAndWarrantsForServices	69101	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	377200	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	557313	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-65083	usd
CY2023	BOF	Increase Decrease In Advances On Inventory Purchases IncreaseDecreaseInAdvancesOnInventoryPurchases	3015	usd
CY2022	BOF	Increase Decrease In Advances On Inventory Purchases IncreaseDecreaseInAdvancesOnInventoryPurchases	-231235	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	177044	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-44208	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	278891	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	438244	usd
CY2023	BOF	Increase Decrease In Rightofuse Asset IncreaseDecreaseInRightofuseAsset	-21092	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	143009	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	12894	usd
CY2023	BOF	Increase Decrease In Accounts Payable Related Party IncreaseDecreaseInAccountsPayableRelatedParty	-40140	usd
CY2022	BOF	Increase Decrease In Accounts Payable Related Party IncreaseDecreaseInAccountsPayableRelatedParty	20115	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-20965	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	390385	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3529372	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2467681	usd
CY2022	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	22714	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	116565	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	45150	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-116565	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-22436	usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	740290	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	351382	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	25000	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	442500	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2694100	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	20000	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	350000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	2420000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	85445	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	239241	usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	91541	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	304032	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	36390	usd
CY2023	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	6226000	usd
CY2022	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	10000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3755279	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2182482	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	109342	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-307635	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	548447	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	856082	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	657789	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	548447	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	466337	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	246661	usd
CY2023	BOF	Value Of Warrants Issued As Debt Discount ValueOfWarrantsIssuedAsDebtDiscount	46090	usd
CY2022	BOF	Value Of Warrants Issued As Debt Discount ValueOfWarrantsIssuedAsDebtDiscount	14050	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	6029204	usd
CY2023	BOF	Initial Recognition Of Rightofuse Assets And Lease Liabilities InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities	168320	usd
CY2022	BOF	Modification Of Derivative Liabilities ModificationOfDerivativeLiabilities	630685	usd
CY2023	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_805_eus-gaap--NatureOfOperations_zW7HDBYnwBOf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 – <span id="xdx_82C_zEdk6ptNpgp6">Nature of Business</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Nature of Business</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BranchOut Food Inc. (“BranchOut,” the “Company,” “we,” “our” or “us”) was incorporated as Avochips Inc. in Oregon on February 21, 2017, and converted into AvoLov, LLC, an Oregon limited liability company, on November 2, 2017. On November 19, 2021, the Company converted from an Oregon limited liability company into BranchOut Food Inc., a Nevada corporation. The Company is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. The Company’s products are currently manufactured for it by two contract manufacturers, one based in Chile and the other in Peru, where BranchOut’s continuous through-put dehydration machine is located. Our manufacturers produce products for us using a new proprietary dehydration technology licensed by the Company. The Company’s customers are primarily located throughout the United States.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	2.5-for-1
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12810541	usd
CY2023Q4	BOF	Working Capital WorkingCapital	-899150	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_z5GW5YHYjqWh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86E_z76tH22raRG1">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	407789	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	62697	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	13734	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	10824	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	323071	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	148937	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	336805	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	159761	usd
CY2022Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	29500	usd
CY2023Q4	BOF	Advances Of Estimated Finish Product Costs Percentage AdvancesOfEstimatedFinishProductCostsPercentage	0.70	pure
CY2023Q4	BOF	Remaining Advances Of Estimated Finish Product Costs Percentage RemainingAdvancesOfEstimatedFinishProductCostsPercentage	0.30	pure
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	223856	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	93253	usd
CY2023	us-gaap	Revenues Revenues	3184018	usd
CY2022	us-gaap	Revenues Revenues	888893	usd
CY2023	BOF	Slotting Discounts And Allowances SlottingDiscountsAndAllowances	358163	usd
CY2022	BOF	Slotting Discounts And Allowances SlottingDiscountsAndAllowances	136715	usd
CY2023	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	2825855	usd
CY2022	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	752178	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	162048	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	199287	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	258574	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	93521	usd
CY2023Q2	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2082	usd
CY2022Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1213	shares
CY2022Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	4.125
CY2022Q1	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	5000	usd
CY2023Q4	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	12500	shares
CY2023Q4	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	19000	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	2403	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	959	usd
CY2023Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	20106	usd
CY2022Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	19485	usd
CY2023Q4	BOF	Prepaid Professional Fees PrepaidProfessionalFees	6056	usd
CY2022Q4	BOF	Prepaid Professional Fees PrepaidProfessionalFees	12617	usd
CY2022Q4	BOF	Refunds Receivable RefundsReceivable	1594	usd
CY2023Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	19535	usd
CY2022Q4	us-gaap	Interest Receivable Current InterestReceivableCurrent	7996	usd
CY2022Q4	BOF	Advances To Co Manufacturer AdvancesToCoManufacturer	455128	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	48100	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	497779	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	761085	usd
CY2023Q4	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	243305	usd
CY2023Q4	us-gaap	Cash Cash	657789	usd
CY2022Q4	us-gaap	Cash Cash	312697	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	235750	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	657789	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	548447	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1233334	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1116769	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	318335	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	94479	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	914999	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1022290	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	223856	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	93253	usd
CY2023	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	214430	usd
CY2022	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	346378	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	377200	usd
CY2023Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	42750	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	91541	usd
CY2023	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	8251	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	43376	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	40089	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2577	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	602246	usd
CY2023Q4	BOF	Accrued Chargebacks AccruedChargebacks	119291	usd
CY2022Q4	BOF	Accrued Chargebacks AccruedChargebacks	46387	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	165244	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	688722	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	34500	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	34500	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	234500	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	2284500	usd
CY2023Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	234500	usd
CY2022Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	2284500	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	200000	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2250000	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	34500	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	34500	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	260520	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	846536	usd
CY2022	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	19886	usd
CY2023	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	214430	usd
CY2022	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	346378	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	377200	usd
CY2023	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	8251	usd
CY2022	us-gaap	Interest Expense Short Term Borrowings InterestExpenseShortTermBorrowings	19886	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	2082	usd
CY2023	us-gaap	Proceeds From Securitizations Of Credit Cards ProceedsFromSecuritizationsOfCreditCards	2406	usd
CY2022	us-gaap	Proceeds From Securitizations Of Credit Cards ProceedsFromSecuritizationsOfCreditCards	2606	usd
CY2023	us-gaap	Interest Expense InterestExpense	435271	usd
CY2022	us-gaap	Interest Expense InterestExpense	2250893	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	200000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	83	usd
CY2023Q4	BOF	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	34417	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	234500	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	234500	usd
CY2023	us-gaap	Lease Cost LeaseCost	168141	usd
CY2023Q4	us-gaap	Share Price SharePrice	1.00
CY2023	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2027-08-31
CY2023Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	3657	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	21092	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	10947	usd
CY2023	BOF	Finance Lease Cost FinanceLeaseCost	32039	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	147228	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	30901	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	101029	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	131930	usd
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y4M6D
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.1100	pure
CY2023	BOF	Repayment Of Finance Lease Liability RepaymentOfFinanceLeaseLiability	36390	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	168320	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	43886	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	43886	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	43886	usd
CY2023Q4	BOF	Finance Lease Liability Payments Due After Year Three FinanceLeaseLiabilityPaymentsDueAfterYearThree	29258	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	160916	usd
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	28986	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	131930	usd
CY2023Q4	BOF	Finance Lease Periodic Payment FinanceLeasePeriodicPayment	3657	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	100000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	250000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	250000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	250000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	850000	usd
CY2023Q4	us-gaap	Other Commitment OtherCommitment	250000	usd
CY2023Q3	us-gaap	Deposits Deposits	50000	usd
CY2023Q4	us-gaap	Deposits Deposits	50000	usd
CY2023Q3	us-gaap	Deposits Deposits	50000	usd
CY2023Q4	us-gaap	Deposits Deposits	50000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	1000	shares
CY2022Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	4125	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	4920	shares
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	20295	usd
CY2023	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	1.60
CY2023	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	6.00
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	169304	shares
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y4M24D
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	3.47
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	79926	shares
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	4.59
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	108404	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.125
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	108404	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.125
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	118500	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.194
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	57600	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.125
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	169304	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.639
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	79926	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.594
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1680000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	932400	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1680000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	932400	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1680000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	932400	usd

Files In Submission

Name	View Source	Status
0001493152-24-012492-index-headers.html	Edgar Link	pending
0001493152-24-012492-index.html	Edgar Link	pending
0001493152-24-012492.txt	Edgar Link	pending
0001493152-24-012492-xbrl.zip	Edgar Link	pending
bof-20231231.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex4-5.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
form10-k_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
bof-20231231_cal.xml	Edgar Link	unprocessable
bof-20231231_def.xml	Edgar Link	unprocessable
bof-20231231_lab.xml	Edgar Link	unprocessable
bof-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BOF
BranchOut Food Inc. Stock $bof

2024 Q1 Form 10-K Financial Statement

#000149315224012492 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BOF BranchOut Food Inc. Stock $bof

2024 Q1 Form 10-K Financial Statement

#000149315224012492 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BOF
BranchOut Food Inc. Stock $bof